PRODUCT DETAILS – Porcilis® Porcoli DF


Product Class

Reg. No. G 3164 Act 36/1947
Nambia Reg. No. V05/24.5/458

Porcilis_PorcoliPorcilis® Porcoli DF is an inactivated vaccine recommended for the passive immunisation of piglets by active immunisation of sows/gilts to reduce mortality and clinical signs, such as diarrhoea due to neonatal enterotoxicosis during the first days of life, caused by those E. coli strains, which express the fimbrial adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99) or F6 (987P).

Storage: Store between +2 ºC and +8 ºC. Do not freeze.
Shelf life after first opening: 3 hours

Each dose of 2mℓ contains the F4ab (K88ab) fimbrial adhesin, the F4ac (K88ac) fimbrial adhesin, the F5 (K99) fimbrial adhesin, the F6 (987P) fimbrial adhesin and LT toxoid, which induce a mean antibody titre of respectively ≥ 9.0 log2 Ab titre, ≥ 5.4 log2 Ab titre, ≥ 6.8 log2 Ab titre, ≥ 7.1 log2 Ab titre and ≥ 6.8 log2 Ab titre after vaccination of mice 1/20 dose. The antigens are adjuvated with 150mg dl-alpha-tocopheryl acetate per dose.


  • This product has a zero day withdrawal period.
  • Vaccinate only healthy animals.
  • Unused vaccine or waste material derived from the product must be disposed of by, for example burning.
  • Do not store partially used containers for future use, and use the entire contents when opened.
  • A mean transient increase in body temperature of about 1ºC, in some pigs up to 3ºC, may occur in the first 24 hours after vaccination.
  • Reduced feed intake and listlessness may occur in approximately 10% of the animals on the day of vaccination, but returns to normal within 1-3 days.
  • A transient swelling and redness at the injection site may be observed in approximately 5% of the animals. The diameter of the swelling is in general below 5cm, but in some cases a larger size may occur.
  • Swelling and redness at the injection site may occasionally last for at least 14 days.
  • Keep out of reach of children and uninformed persons.
  • Although this vaccine has been extensively tested under a large variety of conditions failure thereof may ensue as a result of a wide range of reasons. If this is suspected seek veterinary advice and notify the registration holder.


  • Observe aseptic precautions. Ensure that the vaccination equipment (needles, syringes, etc.) are clean and sterile prior to use.
  • In case of accidental self-injection, seek medical advice immediately and show the package insert or label to the physician.
  • Do not mix the vaccine with any other veterinary medicinal products.

Directions for Use: USE ONLY AS DIRECTED.
Before using the vaccine allow it to reach room temperature (15-25ºC).
Shake well before use.

Dosage and Administration:
Intramuscular injection in sows and gilts of 2mℓ of the vaccine per animal in the neck in the area behind the ear.

Vaccination scheme:
Basic vaccination: Sows/gilts which have not yet been vaccinated with the product shall be given an injection preferably 6 to 8 weeks before the expected date of farrowing and a booster injection 4 weeks later.
Revaccination: A single revaccination shall be carried out during the second half of next pregnancies, preferably 2 to 4 weeks before the expected date of farrowing.

100mℓ glass vials individually packed in cardboard boxes.

Registration holder:
Intervet South Africa (Pty) Ltd
Co. Reg. No. 1991/006580/07
20 Spartan Road,
Spartan, 1619
Tel: +27 (0) 861 838 838